Dr. Guodong Li, MD, PhD

Dr. Li practices at California Rehabilitation Institute in Los Angeles, California, part of Select Medical Holdings.

Dr. Li's NPI, 1588988224, was assigned on March 24, 2010. Dr. Li graduated from Qingdao University Medical College in 1996. Dr. Li holds California license A122667.

Dr. Li's primary practice is California Rehabilitation Institute, at 2070 Century Park East, Los Angeles, CA 90067 in Los Angeles County. The practice phone is (424) 363-1000.

Dr. Li's primary practice is California Rehabilitation Institute in Los Angeles, California, part of Select Medical Holdings. The medical group on file is Pain and Addiction Medicine Associates. Dmand AI also links Dr. Li to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Li practices, 3 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Li's primary specialty in the NPI Registry, under taxonomy code 208VP0000X. The record also lists pain medicine. Dr. Li is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Li's licenses on file in 2 states: California and Missouri.

Dmand AI lists back pain injection, lower back pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Dr. Li treats.

CMS data shows 6,111 Medicare services from Dr. Li across 8 procedure codes in 2024, for 487 Medicare patients. Medicare paid $572,045 for them.

CMS counts 487 Medicare patients who saw Dr. Li in 2024. The largest group is 75 to 84, with 181 patients. 75% of them have arthritis, and 75% have high blood pressure. 30% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Li's median patient age at 64, with 55% women.

In 2024, Dr. Li wrote 1,368 Medicare Part D claims for 293 patients. 98% of them were for generic drugs. CMS names the drug for 1,294 of them, across 22 drugs with 11 or more claims each, at $34,523 in total drug cost. In 2023, CMS named 1,423 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Li for performance year 2024, reported individually. Dr. Li accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Li as offering telehealth.

Dmand AI links 6 papers to Dr. Li, published from 2014 to 2018. 2018 was the busiest year, with 3. The most frequent topics are Disease Models, Animal and Rats, Sprague-Dawley. Dr. Li's most frequent co-author is Bing Wu, MD, PhD.

CMS Open Payments shows 299 general payments to Dr. Li from 29 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 84% of the total. Medtronic USA, Inc. paid the most, $5,579.

Dr. Li graduated from Qingdao University Medical College in 1996.

Dr. Li is in network with 13 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.